PT - JOURNAL ARTICLE AU - Nguyen, Joseph Dan Khoa AU - Mark, Erica AU - Martin, Seth AU - Flowers, R. Hal TI - A Cross-Sectional Analysis of Disparities in Biopsy Result Disclosure for Patients with Limited English Proficiency AID - 10.1101/2024.11.14.24317354 DP - 2024 Jan 01 TA - medRxiv PG - 2024.11.14.24317354 4099 - http://medrxiv.org/content/early/2024/11/15/2024.11.14.24317354.short 4100 - http://medrxiv.org/content/early/2024/11/15/2024.11.14.24317354.full AB - Patients with limited English proficiency (LEP) receiving care from language-discordant providers experience worse outcomes in healthcare quality, safety, and satisfaction, so optimizing medical care for patients with LEP is an integral topic for quality improvement. At our institution, biopsy results are disclosed via telephone unless discussed during an appointment. In this retrospective cohort study, we aimed to quantify the relative lag time in telephone-based biopsy result disclosure when interpretation services were utilized compared to when they were not. A total of 12,372 patient interactions were analyzed; 250 patients (2.02%) required interpreters, and most of these patients spoke Spanish (196, 78.4%). Other languages spoken included Tagalog, Ukrainian, Serbian, Russian, Punjabi, Mandarin, Kurdish, Farsi, Nepali Arabic, and American Sign Language. The mean delay from provider result release to disclosure for patients who required an interpreter was 55.0 hours compared to 36.6 hours for those who did not, respectively (p<0.001). For those requiring a Spanish interpreter, this delay was 60.2 hours (p<0.001). For non-Spanish interpretation, the delay was 36.6 hours (p=0.99). Patients requiring a Spanish interpreter experienced increased mean wait times for receiving biopsy results compared to those who spoke English. Possible reasons include increased communication burden for clinicians when using interpreters, insufficient provider awareness of delays, and patient socioeconomic factors. Future research may analyze the impact of delayed result disclosure, optimal disclosure methods, and initiatives to reduce disparities in time to result disclosure for LEP patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was deemed exempt by the University of Virginia Institutional Review Board.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.